Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab
Clinical trial NCT00301899 · COMPLETED
Trial details
- NCT number
- NCT00301899
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.